OMX30 1 617 -0,2%  OMXH25 3 950 -0,1%  OMXC20 964 1,1%  Dow 20 979 0,0%  Nas 5 565 0,4%  EUR 9,6043 0,5%  USD 8,8275 0,7%  Olja 51,6 0,3%  Guld 1 265 -0,6% 

Baxter International Aktie

55,45USD -0,16USD -0,28%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Baxter International Chart - 1 År - BTT

Fundamentala nyckeltal för Baxter International

2016 2017e 2018e 2019e 2020e
Utdelning 0,50 0,54 0,60 0,68 0,80
Direktavkastning (i %) 1,15 1,19 1,31 1,49 1,76
PE-tal 22,22 20,96 18,56 16,38 14,78
Resultat/aktie 1,96 2,17 2,45 2,77 3,07

Nyheter om Baxter International Inc.

ytterligare nyheter

Analyser om Baxter International Inc.

ytterligare analyser

Baxter International Peer Group

Baxter International 55,45
-0,3%
Boston Scientific 26,12
0,5%
Cardinal Health 73,18
1,2%
Fresenius Medical Care 82,39
0,2%
Fresenius 75,27
1,3%
Medtronic 83,11
1,2%
STRATEC Biomedical 53,43
0,2%
pagehit

Lägg till instrument

Vad tycker du?

Profil Baxter International Inc.till bolagsprofilen

Baxter International, Inc. provides a broad portfolio of essential renal and hospital products, including acute and chronic dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; premixed and oncolytic injectables; biosurgery products and anesthetics; drug reconstitution systems; and pharmacy automation, software and services. The company products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctor's offices and by patients at home under physician supervision. It operates through the following segments: Hospital Products and Renal. The Hospital Products segment intravenous IV solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation. The Renal segment provides products and services to treat end-stage renal disease, or irreversible kidney failure and acute kidney injuries. This segment offers a comprehensive portfolio to meet the needs of patients across the treatment continuum, including technologies and therapies for peritoneal dialysis, in-center hemodialysis, home HD, continuous renal replacement therapy and additional dialysis services. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Realtidskurs Baxter International Inc.

Bid
55,43
USD
Ask
55,45
USD
Kurstid
21:23
Börsen BTT

Aktiekurs Baxter International Inc. i USDPUSH CHART

Kurs 55,45 USD -0,16 -0,28 %
Kurstid 21:23:37
Datum 27.04.2017
Öppning 55,65
Gårdagen 55,60
Dagshögsta 56,50
Dagslägsta 55,44
52 v. högsta 56,50
52 v. lägsta 42,23
52 v. perf.
Volym (Antal) 321 779
Börsvärde (SEK) 251,75 Mrd
Börsen
Kurs för 55,45 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 489,44 SEK.

Till aktien Baxter International

Ticker
ISIN US0718131099
Index S&P 100, NYSE US 100, S&P 500, BX Swiss - USA

Baxter International Nyckeltal

Börsvärde i SEK 251,75 Mrd
Free float % 99,85
Antal aktier mio. 541,96
Cashflow/aktie i lokal valuta 2,28
Bokvärde/aktie i lokal valuta 17,02
60 dagar vola 23,48
PBV 2,56

Baxter International Historiska kurser

2017-04-26 55,60 500 712
2017-04-25 53,21 404 471
2017-04-24 53,45 221 359
2017-04-21 52,89 262 784
2017-04-20 52,89 270 179